Dr. Tom Ksiazek, former head of the CDC Special Pathogens Unit and current director of the High Containment Labotatory Operations at the Galveston National Laboratory, has just returned from Sierra Leone after six weeks there are the top official for the CDC.
As the Ebola virus outbreak rages in West Africa, the world-renowned team of infectious disease experts at the University of Texas Medical Branch at Galveston is at the forefront of the battle against this deadly disease — with clinical research, outbreak response and vaccine development.
Thomas Ksiazek was the head of the Special Pathogens unit at the U.S. Centers for Disease Control and Prevention, leading outbreak response around the world since the mid-‘70s.
Thomas Geisbert has been researching the Ebola virus for more than 25 years, including several years with Fort Detrick's U.S. Army Medical Research Institute of Infectious Disease, working with the world's most vicious viruses. He recently received a $26 million grant from the National Institutes of Health to work on vaccines for the Ebola and Marburg viruses. His work has proven effective in large animal studies.
World Class Research Centers
This expertise and research is made possible by the Galveston National Laboratory , the only fully operational Biosafety Level Four laboratory on an academic campus in the U.S.
The work is enhanced by the capabilities of the Sealy Center for Vaccine Development, one of the most comprehensive vaccine development centers in the world, whose researchers are investigating new ways to treat infectious diseases of every type, from new strains of influenza to emerging diseases from every corner of the globe.
News and Resources